Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?
| dc.contributor.author | Rossignol, Patrick | |
| dc.contributor.author | Agarwal, Rajiv | |
| dc.contributor.department | Medicine, School of Medicine | |
| dc.date.accessioned | 2025-03-11T08:05:58Z | |
| dc.date.available | 2025-03-11T08:05:58Z | |
| dc.date.issued | 2021 | |
| dc.eprint.version | Author's manuscript | |
| dc.identifier.citation | Rossignol P, Agarwal R. Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients? Nephrology Dialysis Transplantation. 2021;36(10):1771. doi:10.1093/ndt/gfab061 | |
| dc.identifier.uri | https://hdl.handle.net/1805/46288 | |
| dc.language.iso | en_US | |
| dc.publisher | Oxford University Press | |
| dc.relation.isversionof | 10.1093/ndt/gfab061 | |
| dc.relation.journal | Nephrology Dialysis Transplantation | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Other | |
| dc.subject | Cardiorenal syndrome | |
| dc.subject | Chronic kidney disease | |
| dc.subject | Hyperkalaemia | |
| dc.subject | Mineralocorticoid receptor antagonist | |
| dc.subject | Renin angiotensin aldosterone system inhibitor | |
| dc.title | Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients? | |
| dc.type | Article |